Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Immunovant Inc’s stock clocked out at $16.39, up 4.06% from its previous closing price of $15.75. In other words, the price has increased by $4.06 from its previous closing price. On the day, 0.96 million shares were traded. IMVT stock price reached its highest trading level at $16.455 during the session, while it also had its lowest trading level at $15.5.
Ratios:
To gain a deeper understanding of IMVT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.16 and its Current Ratio is at 11.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when WILLIAM MACIAS bought 30,000 shares for $15.83 per share.
WILLIAM MACIAS bought 50,000 shares of IMVT for $778,490 on Jun 13 ’25. On Jun 03 ’25, another insider, WILLIAM MACIAS, who serves as the Officer of the company, bought 80,000 shares for $15.61 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2801427968 and an Enterprise Value of 2087558144.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.62, which has changed by -0.37916666 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 8.40%, while the 200-Day Moving Average is calculated to be -26.19%.
Shares Statistics:
It appears that IMVT traded 1.57M shares on average per day over the past three months and 1334530 shares per day over the past ten days. A total of 170.11M shares are outstanding, with a floating share count of 68.57M. Insiders hold about 59.89% of the company’s shares, while institutions hold 55.66% stake in the company. Shares short for IMVT as of 1749772800 were 19918341 with a Short Ratio of 12.69, compared to 1747267200 on 21397625. Therefore, it implies a Short% of Shares Outstanding of 19918341 and a Short% of Float of 22.489999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Immunovant Inc (IMVT) is currently being evaluated by 8.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.71, with high estimates of -$0.63 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.51 and -$3.44 for the fiscal current year, implying an average EPS of -$2.86. EPS for the following year is -$2.82, with 8.0 analysts recommending between -$1.38 and -$3.98.
